• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性黄斑水肿或视网膜静脉阻塞继发黄斑水肿患者在实际临床环境中与标准化阅片中心分析对频域光学相干断层扫描(SD-OCT)成像数据的解读:ORCA研究的24个月随访

Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study.

作者信息

Spital Georg, Schmitz-Valckenberg Steffen, Müller Bettina, Liczenczias Erika, Chang Petrus, Heimes-Bussmann Britta, Ziemssen Focke, Liakopoulos Sandra

机构信息

M3 Reading Centre, Eye Centre at the St. Franziskus Hospital, Münster, Germany.

GRADE Reading Centre, Department of Ophthalmology, University of Bonn, Bonn, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2025 Jan;263(1):131-139. doi: 10.1007/s00417-024-06579-7. Epub 2024 Sep 19.

DOI:10.1007/s00417-024-06579-7
PMID:39294392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11807050/
Abstract

PURPOSE

As part of the prospective, non-interventional OCEAN study, the ORCA module evaluated physicians' spectral domain optical coherence tomography (SD-OCT) image interpretations in the treatment of diabetic macular oedema (DME) or macular oedema (ME) secondary to retinal vein occlusion (RVO).

METHODS

Presence of intraretinal fluid (IRF) and/or subretinal fluid (SRF) was evaluated independently by physicians and reading centres (RCs) on 1612 SD-OCT scans of 133 patients diagnosed with either DME or ME secondary to RVO. Agreement between physicians and RCs was calculated for both cohorts individually and as a combined ME cohort. Physicians' treatment decisions were analysed related to the results of the OCT-evaluations.

RESULTS

For the combined ME cohort, presence of IRF/SRF was recorded by RCs in 792/1612 (49.1%) visits and by physicians in 852/1612 (52.9%) visits, with an agreement regarding presence or absence of foveal fluid in 70.4% of cases. In 64.4% (510/792) of visits with RC-detected foveal IRF and/or SRF no injection was given. In 30.3% of these visits with foveal fluid no reason was identified for a 'watch and wait' approach indicating possible undertreatment. BCVA deterioration was seen in a quarter of these eyes at the following visit.

CONCLUSION

Despite good agreement between physicians and RCs to recognize SRF and IRF, our data indicate that omitting injections despite foveal involvement of fluid is frequent in routine clinical practice. This may put patients at risk of undertreatment, which may negatively impact real-life BCVA outcomes.

TRIAL REGISTRATION

www.

CLINICALTRIALS

gov , identifier NCT02194803.

摘要

目的

作为前瞻性、非干预性OCEAN研究的一部分,ORCA模块评估了医生在治疗糖尿病性黄斑水肿(DME)或视网膜静脉阻塞(RVO)继发的黄斑水肿(ME)时对频域光学相干断层扫描(SD-OCT)图像的解读。

方法

由医生和阅片中心(RCs)对133例诊断为DME或RVO继发ME的患者的1612次SD-OCT扫描独立评估视网膜内液(IRF)和/或视网膜下液(SRF)的存在情况。分别计算两个队列以及合并的ME队列中医生和RCs之间的一致性。分析医生的治疗决策与OCT评估结果的相关性。

结果

对于合并的ME队列,RCs在792/1612(49.1%)次就诊中记录到IRF/SRF的存在,医生在852/1612(52.9%)次就诊中记录到,70.4%的病例在是否存在黄斑区积液方面达成一致。在RCs检测到黄斑区IRF和/或SRF的就诊中,64.4%(510/792)未进行注射。在这些存在黄斑区积液的就诊中,30.3%未发现采取“观察等待”方法的原因,这表明可能存在治疗不足。在随后的就诊中,这些眼睛中有四分之一出现了最佳矫正视力(BCVA)下降。

结论

尽管医生和RCs在识别SRF和IRF方面一致性良好,但我们的数据表明,在常规临床实践中,尽管黄斑区有积液仍经常不进行注射。这可能使患者面临治疗不足的风险,这可能对实际生活中的BCVA结果产生负面影响。

试验注册

www.CLINICALTRIALS.gov,标识符NCT02194803。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86f9/11807050/fb0b3e513708/417_2024_6579_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86f9/11807050/da199e27d792/417_2024_6579_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86f9/11807050/fb0b3e513708/417_2024_6579_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86f9/11807050/da199e27d792/417_2024_6579_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86f9/11807050/fb0b3e513708/417_2024_6579_Fig2_HTML.jpg

相似文献

1
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study.糖尿病性黄斑水肿或视网膜静脉阻塞继发黄斑水肿患者在实际临床环境中与标准化阅片中心分析对频域光学相干断层扫描(SD-OCT)成像数据的解读:ORCA研究的24个月随访
Graefes Arch Clin Exp Ophthalmol. 2025 Jan;263(1):131-139. doi: 10.1007/s00417-024-06579-7. Epub 2024 Sep 19.
2
The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.特发性黄斑裂孔手术后玻璃体内注射曲安奈德的疗效观察
Acta Ophthalmol. 2021 Nov;99(7):e1154-e1161. doi: 10.1111/aos.14746. Epub 2021 Jan 9.
3
MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.光学相干断层扫描渗漏测量在糖尿病性黄斑水肿中的应用:视力反应治疗的生物标志物。
Retina. 2019 Jan;39(1):52-60. doi: 10.1097/IAE.0000000000001905.
4
Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.糖尿病性黄斑水肿和视网膜静脉阻塞患者抗VEGF治疗后黄斑无血管区和黄斑血管密度的光学相干断层扫描血管造影分析
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):30-34. doi: 10.1167/iovs.16-20579.
5
Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.阿柏西普治疗后视网膜血管疾病的纵向全视网膜渗漏和缺血指数:PERMEATE 研究。
Ophthalmol Retina. 2020 Feb;4(2):154-163. doi: 10.1016/j.oret.2019.09.001. Epub 2019 Sep 10.
6
Predictors of macular edema recurrence and visual outcomes in branch retinal vein occlusion treated with aflibercept or ranibizumab.阿柏西普或雷珠单抗治疗视网膜分支静脉阻塞后黄斑水肿复发及视力预后的预测因素
Int Ophthalmol. 2025 Mar 14;45(1):96. doi: 10.1007/s10792-025-03480-y.
7
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.对随机接受雷珠单抗或曲安奈德治疗的糖尿病性黄斑水肿(DME)患者的视网膜形态进行详细分析。
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):49-58. doi: 10.1007/s00417-017-3828-1. Epub 2017 Oct 28.
8
Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial.利用深度学习技术对糖尿病性黄斑水肿患者的液体积聚消退和视力提高程度进行定量评估:一项随机临床试验的事后分析。
JAMA Ophthalmol. 2020 Sep 1;138(9):945-953. doi: 10.1001/jamaophthalmol.2020.2457.
9
Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿后视力预后的频域光学相干断层扫描预测指标
Ophthalmol Retina. 2020 Jan;4(1):67-76. doi: 10.1016/j.oret.2019.08.009. Epub 2019 Aug 28.
10
The Impact of Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review.抗血管内皮生长因子治疗糖尿病性黄斑水肿和视网膜静脉阻塞继发黄斑水肿后残余视网膜液的影响:系统评价。
Ophthalmic Surg Lasers Imaging Retina. 2023 Jan;54(1):50-58. doi: 10.3928/23258160-20221122-01. Epub 2023 Jan 1.

引用本文的文献

1
Cyclodialysis Surgery for Glaucoma Management: A Systematic Review and Meta-Analysis of 100 Years of Clinical Evidence.用于青光眼治疗的睫状体分离术:对100年临床证据的系统评价和荟萃分析
Clin Ophthalmol. 2025 Aug 21;19:2859-2870. doi: 10.2147/OPTH.S538438. eCollection 2025.

本文引用的文献

1
Treatment Patterns and Clinical Outcomes for Central Retinal Vein Occlusion in the Antivascular Endothelial Growth Factor Era.抗血管内皮生长因子时代视网膜中央静脉阻塞的治疗模式与临床结局
J Vitreoretin Dis. 2019 Oct 14;4(1):13-21. doi: 10.1177/2474126419878922. eCollection 2020 Jan-Feb.
2
Questionnaire for the assessment of adherence barriers of intravitreal therapy: the ABQ-IVT.玻璃体内注射治疗依从性障碍评估问卷:ABQ-IVT。
Int J Retina Vitreous. 2021 Jun 2;7(1):43. doi: 10.1186/s40942-021-00311-x.
3
Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial.
利用深度学习技术对糖尿病性黄斑水肿患者的液体积聚消退和视力提高程度进行定量评估:一项随机临床试验的事后分析。
JAMA Ophthalmol. 2020 Sep 1;138(9):945-953. doi: 10.1001/jamaophthalmol.2020.2457.
4
Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration.应用液体自动量化技术于抗 VEGF 治疗新生血管性年龄相关性黄斑变性。
Ophthalmology. 2020 Sep;127(9):1211-1219. doi: 10.1016/j.ophtha.2020.03.010. Epub 2020 Mar 16.
5
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes.糖尿病性黄斑水肿的视力结果和抗 VEGF 治疗强度:28658 例患者眼中的真实世界分析。
Br J Ophthalmol. 2021 Feb;105(2):216-221. doi: 10.1136/bjophthalmol-2020-315933. Epub 2020 Apr 7.
6
Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence.个体化治疗-延长方案,优化真实世界的视力结局,提高患者的依从性。
BMC Ophthalmol. 2020 Mar 30;20(1):122. doi: 10.1186/s12886-020-01397-x.
7
[Not Available].[无可用内容]
Klin Monbl Augenheilkd. 2020 Mar;237(3):325-352. doi: 10.1055/a-1097-3440. Epub 2020 Mar 17.
8
ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD).ORCA 研究:新生血管性年龄相关性黄斑变性(nAMD)的真实世界评估与阅读中心评估疾病活动度的比较。
Br J Ophthalmol. 2020 Nov;104(11):1573-1578. doi: 10.1136/bjophthalmol-2019-315717. Epub 2020 Feb 17.
9
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study.真实世界数据:OCEAN研究中雷珠单抗治疗视网膜静脉阻塞的情况
Clin Ophthalmol. 2019 Nov 7;13:2167-2179. doi: 10.2147/OPTH.S209253. eCollection 2019.
10
Emerging therapies in the management of macular edema: a review.黄斑水肿治疗的新兴疗法:综述
F1000Res. 2019 Aug 12;8. doi: 10.12688/f1000research.19198.1. eCollection 2019.